Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did 😎Read how

Over $42 Million Bet On This Biotechnology Stock? 4 Penny Stocks Insiders are Buying

Published 14/07/2022, 13:15
© Reuters.  Over $42 Million Bet On This Biotechnology Stock? 4 Penny Stocks Insiders are Buying

US producer prices are likely to rise 0.8% on the month in June to match the previous month’s growth. Investors, meanwhile, focused on some notable insider trades.

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.3

SeaChange International

  • The Trade: SeaChange International, Inc. (NASDAQ: SEAC) 10% owner Karen Singer acquired a total of 424,942 shares at an average price of $0.54. To acquire these shares, it cost around $230.22 thousand.
  • What’s Happening: SeaChange, and Triller, last month, announced they mutually agreed to terminate their proposed merger.
  • What SeaChange International Does: SeaChange International Inc is a provider of multiscreen video solutions for television service providers, telecommunications companies, satellite operators, and media companies.
  • The Trade: Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX) 10% owner Innoviva Strategic Opportunities LLC acquired a total of 19,270,476 shares at an average price of $2.20. The insider spent around $42.4 million to buy those shares.
  • What’s Happening: Entasis Therapeutics, last month, highlighted presentation of data on Sulbactam-Durlobactam and ETX0462 at 2022 ASM Microbe Annual Conference.
  • What Entasis Therapeutics Does: Entasis Therapeutics Holdings Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of novel antibacterial products to treat serious infections caused by multidrug-resistant Gram-negative bacteria.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .
Bitcoin

Don’t forget to check out our premarket coverage here .

CalAmp

  • The Trade: CalAmp Corp. (NASDAQ: CAMP) Director Wes Cummins acquired a total of 374,207 shares at an average price of $4.13. To acquire these shares, it cost around $1.55 million.
  • What’s Happening: CalAmp recently reported worse-than-expected Q1 adjusted EPS and sales results.
  • What CalAmp Does: CalAmp Corp provides wireless communications solutions applications to customers.
  • The Trade: Crexendo, Inc. (NASDAQ: CXDO) CEO Steven G Mihaylo acquired a total of 10,000 shares at an average price of $2.89. The insider spent $28.9 thousand to buy those shares.
  • What’s Happening: The company’s stock gained 25% over the past month.
  • What Crexendo Does: Crexendo Inc is a provider of cloud communications, UCaaS, call center, collaboration services, and other cloud business services.

Read at Benzinga

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.